BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 36671441)

  • 1. Diversity of AMPA Receptor Ligands: Chemotypes, Binding Modes, Mechanisms of Action, and Therapeutic Effects.
    Golubeva EA; Lavrov MI; Radchenko EV; Palyulin VA
    Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ligands of the AMPA-subtype glutamate receptors: mechanisms of action and novel chemotypes].
    Radchenko EV; Tarakanova AS; Karlov DS; Lavrov MI; Palyulin VA
    Biomed Khim; 2021 May; 67(3):187-200. PubMed ID: 34142526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.
    Lees GJ
    Drugs; 2000 Jan; 59(1):33-78. PubMed ID: 10718099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affecting AMPA Receptor Biophysical Gating Properties with Negative Allosteric Modulators.
    Qneibi M; Hawash M; Jaradat N; Bdir S
    Mol Neurobiol; 2022 Sep; 59(9):5264-5275. PubMed ID: 35687302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational Analysis and Modeling of Negative Allosteric Modulator Binding Sites in AMPA Receptors.
    Stenum-Berg C; Musgaard M; Chavez-Abiega S; Thisted CL; Barrella L; Biggin PC; Kristensen AS
    Mol Pharmacol; 2019 Dec; 96(6):835-850. PubMed ID: 31582576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPA receptor modulation in previously frozen mouse brain sections: opposite effects of calcium in the cortex and hippocampus.
    Lapierre L; Valastro B; Miceli D; Massicotte G
    Hippocampus; 2000; 10(6):645-53. PubMed ID: 11153710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptic alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor-mediated stimulation of glutamate and GABA release in the rat striatum in vivo: a dual-label microdialysis study.
    Patel DR; Young AM; Croucher MJ
    Neuroscience; 2001; 102(1):101-11. PubMed ID: 11226673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibotenic acid analogues. Synthesis, molecular flexibility, and in vitro activity of agonists and antagonists at central glutamic acid receptors.
    Lauridsen J; Honoré T; Krogsgaard-Larsen P
    J Med Chem; 1985 May; 28(5):668-72. PubMed ID: 2859375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The structure of (-)-kaitocephalin bound to the ligand binding domain of the (S)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/glutamate receptor, GluA2.
    Ahmed AH; Hamada M; Shinada T; Ohfune Y; Weerasinghe L; Garner PP; Oswald RE
    J Biol Chem; 2012 Nov; 287(49):41007-13. PubMed ID: 23076153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing the binding and function of TARP γ8-selective AMPA receptor modulators.
    Dohrke JN; Watson JF; Birchall K; Greger IH
    J Biol Chem; 2020 Oct; 295(43):14565-14577. PubMed ID: 32747446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presynaptic AMPA receptors: more than just ion channels?
    Schenk U; Matteoli M
    Biol Cell; 2004 May; 96(4):257-60. PubMed ID: 15145529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assembly and stoichiometry of the AMPA receptor and transmembrane AMPA receptor regulatory protein complex.
    Kim KS; Yan D; Tomita S
    J Neurosci; 2010 Jan; 30(3):1064-72. PubMed ID: 20089915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptic trafficking of glutamate receptors by MAGUK scaffolding proteins.
    Elias GM; Nicoll RA
    Trends Cell Biol; 2007 Jul; 17(7):343-52. PubMed ID: 17644382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinazolone-alkyl-carboxylic acid derivatives inhibit transmembrane Ca(2+) ion flux to (+)-(S)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid.
    Szárics E; Nyikos L; Barabás P; Kovács I; Skuban N; Temesváriné-Major E; Egyed O; Nagy PI; Kökösi J; Takács-Novák K; Kardos J
    Mol Pharmacol; 2001 Apr; 59(4):920-8. PubMed ID: 11259638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamate Stimulates Local Protein Synthesis in the Axons of Rat Cortical Neurons by Activating α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors and Metabotropic Glutamate Receptors.
    Hsu WL; Chung HW; Wu CY; Wu HI; Lee YT; Chen EC; Fang W; Chang YC
    J Biol Chem; 2015 Aug; 290(34):20748-20760. PubMed ID: 26134564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ionotropic and metabotropic glutamate receptor structure and pharmacology.
    Kew JN; Kemp JA
    Psychopharmacology (Berl); 2005 Apr; 179(1):4-29. PubMed ID: 15731895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
    Baumbarger PJ; Muhlhauser M; Zhai J; Yang CR; Nisenbaum ES
    J Pharmacol Exp Ther; 2001 Jul; 298(1):86-102. PubMed ID: 11408529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphine induction of c-fos expression in the rat forebrain through glutamatergic mechanisms: role of non-n-methyl-D-aspartate receptors.
    Garcia MM; Anderson AT; Edwards R; Harlan RE
    Neuroscience; 2003; 119(3):787-94. PubMed ID: 12809699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Allosteric modulators of AMPA type glutamate receptors a novel gubclass of physiologically active substances].
    Raevskiĭ KS; Eremin KO
    Biomed Khim; 2004; 50(6):523-38. PubMed ID: 15707268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.